Maternal age and amniocentesis: Should this be lowered to 30 years?
- 30 June 1986
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 6 (4) , 237-242
- https://doi.org/10.1002/pd.1970060402
Abstract
We have reviewed the results of 10000 2nd trimester amniocenteses performed at our centre. Over 80 per cent of these were done only because of maternal age (MA); there were three times as many < 35 year‐old women in 1984 compared to 1975. Of women aged 30–34 years at delivery 0·69 per cent were found to have a MA‐related chromosome abnormality compared to 0·94 per cent in those aged 35–40 years. Because only about 7 per cent of births occurred to women ⩾ 35 years and 18·6 per cent between 30–34 years, and a practical utilization rate of 50 per cent, we recommend that amniocentesis be made available to women aged ⩾ 30 years. We believe that 27 per cent of Down syndrome (DS) pregnancies could be identified if 50 per cent of pregnant women in this age category availed themselves of the test. With the same utilization rate, about three times as many amniocenteses would be required in California as performed here in 1983.Keywords
This publication has 8 references indexed in Scilit:
- Projection of Down's syndrome births in the United States 1979-2000, and the potential effects of prenatal diagnosis.American Journal of Public Health, 1983
- Trends in utilization of prenatal cytogenetic diagnosis by New York State residents in 1979 and 1980.American Journal of Public Health, 1983
- CHROMOSOME-ABNORMALITIES AND SPONTANEOUS FETAL DEATH FOLLOWING AMNIOCENTESIS - FURTHER DATA AND ASSOCIATIONS WITH MATERNAL AGE1983
- INFLUENCE OF DEMOGRAPHIC FACTORS ON ANNUAL DOWN'S SYNDROME BIRTHS IN OHIO, 1970–1979, AND THE UNITED STATES, 1920–19791American Journal of Epidemiology, 1982
- Utilization of prenatal genetic diagnosis in women 35 years of age and older in the United States, 1977 to 1978American Journal of Obstetrics and Gynecology, 1981
- FOLLOW-UP OF 2000 2ND-TRIMESTER AMNIOCENTESES1980
- Chromosome findings in 2,500 second trimester amniocentesesAmerican Journal of Medical Genetics, 1980
- Preventing the birth of infants with Down's syndrome: a cost-benefit analysis.BMJ, 1976